| Enhancer ID: | E_01_0058 |
| Species: | human |
| Position : | chr5:88714680-88716680 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Dilated cardiomyopathy |
| Pubmed ID: | 28902616 |
| Enhancer experiment: | Transfection,dual-luciferase reporter assay |
| Enhancer experiment description: | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
| Target gene : | -- |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
| TF name : | MEF2C(5430401D19Rik,9930028G15Rik,AV011172,Mef2) |
| TF experiment: | Transfection,dual-luciferase reporter assay |
| TF experiment description: | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
| Enhancer function : | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
| SNP ID: | -- |